Unity Touts Positive Data From Diabetic Macular Edema Study, Plans Head-To-Head Study With Regeneron's Eylea
April 24, 2023 at 11:34 AM EDT
UNITY Biotechnology Inc(NASDAQ: UBX)announced resultsfrom the long-term follow-up of the Phase 2 BEHOLD study of ...